Uses of dual NK1/NK3 receptor antagonists for treating sex-hormone diseases
US10195205B2 · kind B2 · utility
4Cited by
2References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 18, 2016 |
| Grant date | Feb 5, 2019 |
| Priority date | — |
| Expiry date | May 18, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0095
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to new use of dual NK-1/NK-3 receptor antagonists or a pharmaceutically acceptable salt thereof in the treatment of sex-hormone dependent diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.